Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial Networks.

Loading...
Thumbnail Image

Date

2016-08-15

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

122
views
128
downloads

Citation Stats

Abstract

The economics of antibiotics can be improved by infectious diseases-specific clinical trial networks. While developers would still need to implement an independent phase 1 program as well as studies focused on highly resistant pathogens, standardized procedures in a network focused on usual drug resistance phenotype isolates would permit sharing of controls and would predictably generate high-quality pivotal data for product registration while creating cost and time savings in the range of 30%-40%. This would reduce economic barriers to antibiotic development and contribute to public health.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1093/cid/ciw244

Publication Info

McDonnell, Anthony, John H Rex, Herman Goossens, Marc Bonten, Vance G Fowler and Aaron Dane (2016). Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial Networks. Clin Infect Dis, 63 Suppl 2. pp. S57–S59. 10.1093/cid/ciw244 Retrieved from https://hdl.handle.net/10161/13300.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Fowler

Vance Garrison Fowler

Florence McAlister Distinguished Professor of Medicine

Determinants of Outcome in Patients with Staphylococcus aureus Bacteremia
Antibacterial Resistance
Pathogenesis of Bacterial Infections
Tropical medicine/International Health


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.